Income Taxes	9 Months Ended
Oct. 03, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 12. INCOME TAXES Our income tax expense was $5.7 million for the three months ended October 3, 2020, compared with income tax expense of $3.9 million for the three months ended September 28, 2019. Our effective tax rate for the three months ended October 3, 2020, was an expense rate of 24.7%, and was an expense rate of 20.4% for the three months ended September 28, 2019. Our income tax expense was $9.4 million for the first nine months of 2020, compared with income tax expense of $11.3 million for the first nine months of 2019. Our effective tax rate for the nine months ended October 3, 2020, was an expense rate of 21.0%, and was an expense rate of 21.8% for the nine months ended September 28, 2019. Income tax expense in the three months ended October 3, 2020 included no discrete items of income tax, and in the nine months ended October 3, 2020 includes several discrete items of income tax benefits, including federal and state research and development tax credit true-ups to actual from the assumptions we made when preparing our 2019 tax provision, which totaled $319 thousand, and a refund from the state of Florida relating to excess taxes received by the state caused by the Tax Cuts and Jobs Act of 2017, which was $700 thousand, which benefitted tax expense by $553 thousand, net of its Federal tax effect. For the three and nine months ended September 28, 2019, there were federal and state research and development tax credit true-ups totaling $146 thousand. Excess tax benefits relating to equity awards, treated as a discrete item of income tax, were zero in the three months ended October 3, 2020, and were $665 thousand in the three months ended September 28, 2019. Excess tax benefits were $737 thousand in the nine months ended October 3, 2020, and were $1.7 million in the nine months ended September 28, 2019. Excluding discrete items of income tax, the effective tax rates for the three months ended October 3, 2020, and September 28, 2019, would have been income tax expense rates of 24.7% and 24.8%, respectively. Excluding discrete items of income tax, the effective tax rates for the nine months ended October 3, 2020, and September 28, 2019, would have been income tax expense rates of 24.6% and 25.3%, respectively. Our estimated annual effective tax rate, excluding the discrete items discussed above, approximates our current combined statutory federal and state rate of 25.0%. In response to the Pandemic, in March 2020, the U.S. Congress passed the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) legislation aimed at providing relief for individuals and businesses that have been negatively impacted by the Pandemic. The CARES Act did not have a material impact to our consolidated financial statements. During the three months ended October 3, 2020, we made payments of estimated Federal and state income taxes totaling $4.0 million. We made no payments of estimated Federal or state income taxes prior to the third quarter of 2020, as the deadlines for such payments to the United States government, and the majority of states in which we have nexus, which followed the payment deadline extension of the CARES Act, had been deferred until July 15, 2020. However, we received a refund from the state of Florida relating to excess taxes received by the state caused by the Tax Cuts and Jobs Act of 2017, described above, which was $700 thousand, before Federal effect. During the three and nine months ended September 28, 2019, we made payments of estimated Federal and state income taxes totaling $4.3 million and $10.8 million, respectively.

Income Taxes

9 Months Ended

Oct. 03, 2020

NOTE 12. INCOME TAXES

Our income tax expense was $5.7 million for the three months ended October 3, 2020, compared with income tax expense of $3.9 million for the three months ended September 28, 2019. Our effective tax rate for the three months ended October 3, 2020, was an expense rate of 24.7%, and was an expense rate of 20.4% for the three months ended September 28, 2019. Our income tax expense was $9.4 million for the first nine months of 2020, compared with income tax expense of $11.3 million for the first nine months of 2019. Our effective tax rate for the nine months ended October 3, 2020, was an expense rate of 21.0%, and was an expense rate of 21.8% for the nine months ended September 28, 2019.

Income tax expense in the three months ended October 3, 2020 included no discrete items of income tax, and in the nine months ended October 3, 2020 includes several discrete items of income tax benefits, including federal and state research and development tax credit true-ups to actual from the assumptions we made when preparing our 2019 tax provision, which totaled $319 thousand, and a refund from the state of Florida relating to excess taxes received by the state caused by the Tax Cuts and Jobs Act of 2017, which was $700 thousand, which benefitted tax expense by $553 thousand, net of its Federal tax effect. For the three and nine months ended September 28, 2019, there were federal and state research and development tax credit true-ups totaling $146 thousand. Excess tax benefits relating to equity awards, treated as a discrete item of income tax, were zero in the three months ended October 3, 2020, and were $665 thousand in the three months ended September 28, 2019. Excess tax benefits were $737 thousand in the nine months ended October 3, 2020, and were $1.7 million in the nine months ended September 28, 2019.

Excluding discrete items of income tax, the effective tax rates for the three months ended October 3, 2020, and September 28, 2019, would have been income tax expense rates of 24.7% and 24.8%, respectively. Excluding discrete items of income tax, the effective tax rates for the nine months ended October 3, 2020, and September 28, 2019, would have been income tax expense rates of 24.6% and 25.3%, respectively.

Our estimated annual effective tax rate, excluding the discrete items discussed above, approximates our current combined statutory federal and state rate of 25.0%.

In response to the Pandemic, in March 2020, the U.S. Congress passed the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) legislation aimed at providing relief for individuals and businesses that have been negatively impacted by the Pandemic. The CARES Act did not have a material impact to our consolidated financial statements. During the three months ended October 3, 2020, we made payments of estimated Federal and state income taxes totaling $4.0 million. We made no payments of estimated Federal or state income taxes prior to the third quarter of 2020, as the deadlines for such payments to the United States government, and the majority of states in which we have nexus, which followed the payment deadline extension of the CARES Act, had been deferred until July 15, 2020. However, we received a refund from the state of Florida relating to excess taxes received by the state caused by the Tax Cuts and Jobs Act of 2017, described above, which was $700 thousand, before Federal effect. During the three and nine months ended September 28, 2019, we made payments of estimated Federal and state income taxes totaling $4.3 million and $10.8 million, respectively.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details